SCHEMBL18573293

SCHEMBL18573293

O=C(c1cc(C(=O)N(c2ccccc2)c2ccc(-c3ccccn3)cc2)cc(C(=O)N(c2ccccc2)c2ccc(-c3ccccn3)cc2)c1)N(c1ccccc1)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.48
BCR P11274 1/20 0.48
DHODH Q02127 1/20 0.47
KDM4E B2RXH2 1/20 0.45
KDM6B O15054 1/20 0.45
KDM4A O75164 1/20 0.45
KDM5C P41229 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
KDM2A Q9Y2K7 1/20 0.45
KDM3A Q9Y4C1 1/20 0.45
TP53 P04637 1/20 0.44
KAT6A Q92794 1/20 0.43
NR3C2 P08235 1/20 0.43
SLC6A7 Q99884 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
TRPV1 Q8NER1 2/20 0.41
CHEK2 O96017 2/20 0.41
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18573166 0.82 ABL1 (0.51) ABL1BCRDHODHKDM4ETRPV1
SCHEMBL9001706 0.79 NPSR1 (0.58) KDM4ENR3C2ESR1ESR2NPC1
SCHEMBL19781185 0.77 ABL1 (0.44) ABL1BCRDHODHSLC6A7TRPV1
SCHEMBL22059856 0.77 ABL1 (0.46) ABL1BCRDHODHKDM4ETRPV1
SCHEMBL19933610 0.77 ABL1 (0.46) ABL1BCRKDM4ETRPV1RAB9A
SCHEMBL6356563 0.76 KDM4E (0.50) ABL1BCRDHODHKDM4ETP53
SCHEMBL21012595 0.76 KDM4E (0.50) ABL1BCRDHODHKDM4ETP53
SCHEMBL9001691 0.75 ESR1 (0.54) NR3C2ESR1ESR2NPC1LMNA
SCHEMBL29788328 0.74 KDM4E (0.61) DHODHKDM4EKDM6BKDM4AKDM5C
SCHEMBL5858 0.74 KDM4E (0.61) DHODHKDM4EKDM6BKDM4AKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031562-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-08 US disclosed
WO-2017032439-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031562-B2 Metal complexes AP1M1, SOD1, AP3M1 ABL1 1894/4885BCR 3772/4885DHODH 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.